Pulmonary Gas Exchange Abnormalities in Patients With Mild COPD

Sponsor
Queen's University (Other)
Overall Status
Completed
CT.gov ID
NCT02346604
Collaborator
Ontario Lung Association (Other)
22
1
18
1.2

Study Details

Study Description

Brief Summary

People with mild chronic obstructive pulmonary disease (COPD) can have significant physiological abnormalities and breathing inefficiency which become more pronounced during the stress of exercise, leading to intolerable breathing discomfort (dyspnea). To better understand the mechanisms of respiratory symptoms and exercise limitation in mild COPD, we will examine detailed lung function tests and other important measurements during rest and exercise in people with mild COPD compared with healthy non-smokers. This will be the first study to uncover the fundamental causes of breathing inefficiency and the related shortness of breath during physical exertion in patients with mild COPD. We hope to demonstrate that one simple measurement during exercise [the relation (ratio) between the total amount of air breathed (ventilation) and the amount of carbon dioxide breathed out] gives meaningful information about the extent of damage to the small airways and blood vessels in mild COPD and the overall gas exchanging function of the lungs, without the need for an arterial blood sample.

This is a case-controlled observational study not involving an intervention. Participants will complete 2 visits approximately 1 week apart, each conducted at the same time of day. Visit 1 will consiste of screening for iligibility, symptom and activity assessments, pulmonary function tests and an incremental cycle cardiopulmonary exercise test (CPET) for familiarization purposes. Visit 2 will include spirometry followed by an incremental cycle CPET with detailed measures of ventilatory, gas exchange, sensory-perceptual and arterial blood gas responses.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    22 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    Pulmonary Gas Exchange Abnormalities in Patients With Mild COPD
    Study Start Date :
    Jul 1, 2013
    Actual Primary Completion Date :
    Jan 1, 2015
    Actual Study Completion Date :
    Jan 1, 2015

    Arms and Interventions

    Arm Intervention/Treatment
    Mild COPD

    Symptomatic smokers with mild COPD

    Healthy Control

    Non-smokers, matched to mild COPD group for age (at least 50 years) and gender

    Outcome Measures

    Primary Outcome Measures

    1. ventilatory equivalent for carbon dioxide (VE/VCO2) [Measured at its nadir during an exercise test. Participants will be followed for the amount of time taken to complete 2 study visits, an expected average duration between 1 and 2 weeks.]

      Exercise will consist of a symptom-limited incremental test on a cycle ergometer

    Secondary Outcome Measures

    1. dead space to tidal volume ratio (VD/VT) [Measured at standardized work rates during exercise]

    2. arterial blood gas measurements [Measured at standardized work rates during exercise]

      Measurements will include arterial oxygen tension (PaO2), arterial carbon dioxide tension (PaCO2), pH, hydrogen ion (H+), plasma bicarbonate (HCO3-) and lactate.

    3. dyspnea intensity measured using the modified 10-point Borg scale [Measured at standardized work rates during exercise]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    50 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Stable symptomatic patients with GOLD grade 1B mild COPD;

    • at least 50 years of age;

    • a cigarette smoking history ≥20 pack-years;

    • a Baseline Dyspnea Index focal score ≤9;

    • post-bronchodilator forced expiratory volume in 1 second (FEV1) ≥80 %predicted and an FEV1/forced vital capacity (FVC) ratio <0.7 and < lower limit of normal.

    Exclusion Criteria:
    • clinically significant comorbidities;

    • contraindications to exercise testing;

    • history/clinical evidence of asthma;

    • body mass index <18.5 or >30 kg/m2;

    • use of supplemental oxygen.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Respiratory Investigation Unit at Kingston General Hospital Kingston Ontario Canada K7L 2V7

    Sponsors and Collaborators

    • Queen's University
    • Ontario Lung Association

    Investigators

    • Principal Investigator: Denis E O'Donnell, MD, FRCPC, Queen's University and Kingston General Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Dr. Denis O'Donnell, Principal Investigator, Queen's University
    ClinicalTrials.gov Identifier:
    NCT02346604
    Other Study ID Numbers:
    • DMED-1458-12
    First Posted:
    Jan 27, 2015
    Last Update Posted:
    Nov 20, 2015
    Last Verified:
    Nov 1, 2015
    Keywords provided by Dr. Denis O'Donnell, Principal Investigator, Queen's University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 20, 2015